Please Wait
Applying Filters...
menu
    • menu
    Mikart-PSE
    News
    MiKART, Benuvia Partner for Controlled Drug Solutions

    23 Apr 2026

    // PR NEWSWIRE

    Transforming Drug Delivery with Advanced Nanotechnology

    11 Feb 2026

    // PRESS RELEASE

    Mikart, Nano Pharma Report Positive Ph 1 NT-301 Data, Expansion

    18 Sep 2025

    // PR NEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    Mikart

    Contact Supplier

    Website

    Contract Pharma

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/mikart/solid-foundation-flexible-solutions
    Left Arrow
    Right Arrow

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Related CompaniesRelated Companies

    About

    Mikart is a privately owned contract development and manufacturing organization (CDMO) that has consistently delivered top-notch products for over 50 years. Mikart’s capabilities span across various areas, such as product development, regulatory services, clinical trial supplies, analytical services, solid or liquid oral dose manufacturing and packaging. Mikart's specialty lies in non-sterile oral liquid and oral solid dosage forms, particularly in controlled substances, geriatrics and pediatrics, from formulation to full-scale commercialization. Mikart adheres to all current FDA and cGMP standards to ensure top-quality output.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.